UK markets closed

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3400+0.0100 (+0.75%)
At close: 04:00PM EDT
1.3303 -0.01 (-0.72%)
After hours: 07:10PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-51,925
-51,925
-94,226
-282,024
-384,841
Depreciation & amortisation
41,846
41,846
35,280
36,128
32,655
Deferred income taxes
-33,217
-
-
0
0
Stock-based compensation
9,317
9,317
17,849
22,735
24,460
Change in working capital
-20,727
-20,727
-1,443
-105,611
-12,855
Accounts receivable
994
994
11,297
-24,027
11,669
Inventory
-2,542
-2,542
19,087
-24,947
6,163
Accounts payable
-5,244
-5,244
1,501
-11,735
3,678
Other working capital
-23,384
-23,384
-73,268
-253,024
-110,705
Other non-cash items
-2,715
-2,715
-60,202
39,798
26,648
Net cash provided by operating activities
-23,384
-23,384
-73,154
-252,965
-110,388
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-114
-59
-317
Purchases of investments
-
-
0
0
-99,932
Sales/maturities of investments
-
-
0
40,000
60,245
Net cash used for investing activities
0
0
-114
39,941
-40,004
Cash flows from financing activities
Debt repayment
-15,006
-32,000
-33,000
0
0
Common stock issued
6,708
6,708
7,121
88,202
209,419
Common stock repurchased
-
-
-
0
0
Other financing activities
-
-
40,000
44,783
-
Net cash used provided by (used for) financing activities
-25,206
-25,206
14,598
133,731
231,720
Net change in cash
-48,590
-48,590
-58,670
-79,293
81,328
Cash at beginning of period
93,169
93,169
151,839
231,132
149,804
Cash at end of period
44,579
44,579
93,169
151,839
231,132
Free cash flow
Operating cash flow
-23,384
-23,384
-73,154
-252,965
-110,388
Capital expenditure
-
-
-114
-59
-317
Free cash flow
-23,384
-23,384
-73,268
-253,024
-110,705